Search clinical trials for: Tumour response
Total 14357 results
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
Erasmus Medical CenterNot yet recruitingPathological Response Rate, Circulating Tumour DNA
-
Dr. Christopher MuellerCanadian Institutes of Health Research (CIHR); Queen's UniversityRecruitingMetastatic Breast CancerCanada
-
Royal Marsden NHS Foundation TrustRecruitingHead and Neck CancerUnited Kingdom
-
D'Or Institute for Research and EducationHalioDx; Diagnosticos da America SARecruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; FONCER contre...RecruitingRenal Cell Carcinoma | Renal Cancer | Renal Cancer MetastaticFrance
-
Assiut UniversityRecruitingSafety of Excision the New Tumor SizeEgypt
-
Sheba Medical CenterBristol-Myers SquibbRecruitingStage IV Pancreatic CancerIsrael
-
University of ManchesterThe Christie NHS Foundation TrustRecruiting
-
Imperial College LondonCuresponse Ltd.Not yet recruitingMetastatic Cancer | Advanced Cancer
-
University of ManchesterCancer Research UK; Centre for Trials Research, Cardiff UniversityRecruitingOvary CancerUnited Kingdom
-
University of Roma La SapienzaRecruitingNeuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Neoplasm | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1Italy
-
Sahlgrenska University Hospital, SwedenGöteborg UniversityRecruiting
-
Maria Sklodowska-Curie National Research Institute...Polish Society of Surgical OncologyRecruitingRectal Cancer | Rectal NeoplasmsPoland
-
University Hospital, RouenInstitut Curie; APHPRecruitingBladder Cancer | Chemotherapy EffectFrance
-
NHS LothianRecruitingProstate Cancer | DNA Damage | Volatile Organic Compounds | Radiotherapy Side EffectsUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
IRCCS San RaffaeleActive, not recruitingNeuroendocrine Tumors | GEP-NETItaly
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
University Hospital, BordeauxActive, not recruiting
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States, France, Spain
-
Sahlgrenska University Hospital, SwedenGöteborg UniversityActive, not recruiting
-
University College, LondonBoehringer IngelheimCompletedNon-small Cell Lung CancerUnited Kingdom
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Allarity TherapeuticsDanish Breast Cancer Cooperative Group; Smerud Medical Research International...Active, not recruiting
-
Walter and Eliza Hall Institute of Medical ResearchJohns Hopkins UniversityActive, not recruitingOvarian CancerAustralia, United States
-
Guangdong Provincial People's HospitalCompletedChemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, ResidualChina
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsCompletedProstate Cancer MetastaticNetherlands
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsCompletedProstate Cancer MetastaticNetherlands
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
AZ Sint-Jan AVActive, not recruitingHead and Neck Cancer | Multiparametric MRI | Cervical Lymph Node | Treatment Response | Bone Invasion | Tumour RelapseBelgium
-
Klinik FavoritenCompletedGastrointestinal NeoplasmAustria
-
Institute of Cancer Research, United KingdomKortuc, Inc.Completed
-
Lund University HospitalCompletedMetastatic Breast CancerSweden
-
Centre Leon BerardTerminatedSarcoma | Rectal Carcinoma | Esophagus CancerFrance
-
IpsenCompletedNeuroEndocrine TumoursUnited Kingdom
-
Cairo UniversityMohamed, Ahmed A., M.D.; Tarek Ahmed Radwan; Mohamed Farid Mohamed; Hamed Fathy...CompletedLMA Versus Mgso4 in Attenuating Stress Response During Emergence of Supratentorial Tumours PatientsEgypt
-
University Hospital, RouenUnknownMetastatic Colorectal Cancer | Circulating MarkersFrance
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Spanish Cooperative Group for the Treatment of...TerminatedColorectal CarcinomaSpain
-
AHS Cancer Control AlbertaUnknown
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
National University Hospital, SingaporeTerminated
-
Auron Healthcare GmbHTerminatedHepatocellular CarcinomaGermany
-
All India Institute of Medical Sciences, New DelhiUnknownHepatocellular CarcinomaIndia
-
Mashhad University of Medical SciencesRoche Pharma AGCompletedDMARD Resistant Rheumatoid ArthritisIran, Islamic Republic of
-
Novartis PharmaceuticalsCompleted